Detalhe da pesquisa
1.
Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection.
Proc Natl Acad Sci U S A
; 116(49): 24748-24759, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31748275
2.
Differential Immunodominance Hierarchy of CD8+ T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 Infection.
J Virol
; 92(4)2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29167337
3.
Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections.
Proc Natl Acad Sci U S A
; 111(33): 12187-92, 2014 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25092293
4.
Hybrid spreading mechanisms and T cell activation shape the dynamics of HIV-1 infection.
PLoS Comput Biol
; 11(4): e1004179, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25837979
5.
Emergence of a distinct HIV-specific IL-10-producing CD8+ T-cell subset with immunomodulatory functions during chronic HIV-1 infection.
Eur J Immunol
; 43(11): 2875-85, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23897063
6.
Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors.
Blood
; 119(21): 4928-38, 2012 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22490682
7.
Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Retrovirology
; 10: 146, 2013 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24299076
8.
Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.
PLoS Pathog
; 7(2): e1001273, 2011 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21347345
9.
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.
Retrovirology
; 8: 16, 2011 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21401915
10.
Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection.
Retrovirology
; 8: 41, 2011 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21635736
11.
Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection.
J Immunol
; 182(11): 7131-45, 2009 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19454710
12.
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
bioRxiv
; 2021 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33619489
13.
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
Res Sq
; 2021 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758833
14.
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.
Nat Commun
; 12(1): 5839, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34611163
15.
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption.
Sci Transl Med
; 13(576)2021 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33441429
16.
Dynamics of Transforming Growth Factor (TGF)-ß Superfamily Cytokine Induction During HIV-1 Infection Are Distinct From Other Innate Cytokines.
Front Immunol
; 11: 596841, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33329587
17.
Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.
Front Immunol
; 9: 474, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29616021
18.
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth.
Cell Rep
; 25(4): 893-908.e7, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30355496
19.
Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV.
Lancet HIV
; 8(6): e317-e318, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34087093
20.
In vivo emergence of HIV-1 highly sensitive to neutralizing antibodies.
PLoS One
; 6(8): e23961, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21887353